Use of high contrast film-screen systems in mammography, in combination with the fact that exposure parameters are selected to ensure good visualization of the mammary gland, results in overexposure of the film area corresponding to the breast periphery, therefore decreasing image quality. The aim of this work was to provide a quantitative evaluation of image quality at the breast periphery compared with the mammary gland. To deal with the difficulties in quantification of image quality introduced by low contrast encountered at the breast periphery, wavelet analysis has been used for derivation of a contrast indicator (CI) and a noise indicator (NI), taking into account local grey level variations. Gradient magnitude coefficients corresponding to region of interest (ROI) grey level values are the basis of CI definition. Mammary gland and breast periphery were sampled by equally spaced ROIs, the quantity of which was determined by a heuristic method. For NI definition, the power values of gradient magnitude coefficients corresponding to the ROI were utilized. Image quality at the breast periphery compared with the mammary gland was evaluated using 150 craniocaudal images from the Digital Database for Screening Mammography. Measurements were carried out using a tool developed in our department. A 50% contrast decrease at the breast periphery was observed, while noise decreased by approximately 2%.
Four‐dimensional computerized tomography (4DCT) is required for stereotactic ablative body radiotherapy (SABR) of mobile targets to account for tumor motion during treatment planning and delivery. In this study, we report on the impact of an image review quality assurance process performed prior to treatment planning by medical physicists for 4DCT scans used for SABR treatment. Reviews were performed of 211 4DCT scans (193 patients) over a 3‐yr period (October 2014 to October 2017). Treatment sites included lung (n = 168), kidney/adrenal/adrenal gland (n = 12), rib (n = 4), mediastinum (n = 10), liver (n = 2), T‐spine (n = 1), and other abdominal sites (n = 14). It was found that in 23% (n = 49) of cases patient management was altered due to the review process. The most frequent intervention involved patient‐specific contouring advice (n = 35 cases, 17%) including adjustment of internal target volume (ITV) margins. In 13 cases (6%) a rescan was requested due to extensive motion artifact rendering the scan inadequate for SABR treatment planning. 4DCT review by medical physicists was found to be an effective method to improve plan quality for SABR.
Breast cancer is amongst the leading radiation‐associated, second malignancies that develop in patients after treatment for Hodgkin's disease. This risk is affected by two main factors:
The age of the patient at the time of radiotherapy; and
The dose received by the breast tissue
The adolescent female thus faces an exceptionally high risk, as breast tissue at this age is undergoing rapid developmental growth and small doses of radiation exposure could be carcinogenic. This case report of a fifteen‐year‐old girl who received radiotherapy for Hodgkin's disease demonstrates how radiation therapists worked together with the radiation oncologists and medical physicists to provide an optimal treatment plan for a high‐risk patient.
IntroductionTotal body irradiation (TBI) practices vary considerably amongst centres, and the risk of treatment related toxicities remains unclear. We report lung doses for 142 TBI patients who underwent either standing TBI with lung shield blocks or lying TBI without blocks.MethodsLung doses were calculated for 142 TBI patients treated between June 2016 and June 2021. Patients were planned using Eclipse (Varian Medical Systems) using AAA_15.6.06 for photon dose calculations and EMC_15.6.06 for electron chest wall boost fields. Mean and maximum lung doses were calculated.ResultsThirty‐seven patients (26.2%) were treated standing using lung shielding blocks with 104 (73.8%) treated lying down. Lowest relative mean lung doses were achieved using lung shielding blocks in standing TBI, reducing the mean lung doses to 75.2% of prescription (9.9 Gy), ±4.1% (range 68.6–84.1%) for a prescribed dose of 13.2 Gy in 11 fractions, including contributions from electron chest wall boost fields, compared to 12 Gy in 6 fraction lying TBI receiving 101.6% mean lung dose (12.2 Gy) ±2.4% (range 95.2–109.5%) (P ≪ 0.05). Patients treated lying down with 2 Gy single fraction received the highest relative mean lung dose on average, with 108.4% (2.2 Gy) ±2.6% of prescription (range 103.2–114.4%).ConclusionLung doses have been reported for 142 TBI patients using the lying and standing techniques described herein. Lung shielding blocks significantly reduced mean lung doses despite the addition of electron boost fields to the chest wall.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.